53 results on '"Bui, S."'
Search Results
2. Aspergillose bronchopulmonaire allergique (ABPA) et mucoviscidose : mécanismes, diagnostic et alternatives thérapeutiques
3. The impact of chest computed tomography and chest radiography on clinical management of cystic fibrosis lung disease
4. Acclimating salmon as juveniles prepares them for a farmed life in sea-cages
5. Dépistage néonatal de la mucoviscidose en France : aspects pratiques et perspectives
6. Nouvelles thérapeutiques de la mucoviscidose ciblant le gène ou la protéine CFTR
7. Dépistage néonatal et prise en charge précoce de la mucoviscidose
8. Human papillomavirus (HPV) status of non-tobacco related squamous cell carcinomas of the lateral tongue
9. Consensus national sur les modalités de prescription des corticoïdes inhalés dans la mucoviscidose
10. L’inflammation pulmonaire dans la mucoviscidose
11. Nouvelles thérapeutiques ciblant le canal chlorure dans la mucoviscidose
12. Nouvelles techniques d'évaluation dans la mucoviscidose
13. Premier cas d’induction de tolérance au Kaftrio® chez l’enfant
14. 2125P Potential ROle of hypoVItaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): A prospective observational study
15. P086 The French clinical research network in cystic fibrosis more than 10 years of positive experience in clinical research for patients
16. Intérêt pratique du dosage de l'élastase-1 fécale chez l'enfant : comparaison au dosage de la chymotrypsine fécale
17. P247 Improved quality of care increases lung function and growth parameters in children with cystic fibrosis
18. P155 Pharmacokinetic of aminoglycosides in children with cystic fibrosis
19. P123 Management of Pseudomonas aeruginosa infections in cystic fibrosis patients in France
20. WS03.4 Lumacaftor/ivacaftor improves the intestinal inflammation in children with cystic fibrosis
21. P412 Patient and parent perception regarding clinical research in south-west France
22. P265 Real-life initiation of lumacaftor/ivacaftor in adolescents and adults homozygous for the F508del CFTR mutation: a French nationwide study
23. P147 Burkholderia primo-infection treatment in cystic fibrosis patients: report of 17 cases
24. P151 Feasibility of following up the benefits of a rehabilitation program by telehomecare in children with cystic fibrosis
25. P052 Late impact of early chronic methicillin-sensitive Staphylococcus aureus (MSSA) infection in children with cystic fibrosis
26. P025 Lumacaftor/ivacaftor in real life for Phe508del homozygous, adolescents with severe and normal lung function
27. V10 - Intensive mucositis management in head and neck cancer patients treated with concomitant chemo-radiotherapy: the pivotal role of the nurse
28. 314 Intake of liposoluble vitamins from food and vitamin supplementation in children with CF
29. 253 Intensive rehabilitation program combined with educational intervention in children with cystic fibrosis and impaired lung function
30. 263 Improvement of quality of care: the Phare-M program in Bordeaux paediatric CF centre
31. 173 Impact of intravenous antibiotics on the gut microbiota in children with cystic fibrosis
32. EPS6.2 Feasibility of telehomecare (THC) in children with cystic fibrosis (CF)
33. WS16.2 Assessment by physiotherapists of morphostatic and perineal sphincter disorders in children with CF
34. Mesure des produits avancés de glycation (AGE) chez l’enfant mucoviscidosique
35. CO-74 – Évaluation du dépistage du diabète chez les enfants atteints de mucoviscidose
36. CO-12 – Évolutivité de l'atteinte hépatique de la mucoviscidose étudiée par élastométrie impulsionnelle
37. CO-13 – Mesure des produits avancés de glycation (AGE) chez l'enfant mucoviscidosique
38. P209 Évaluation des pratiques professionnelles de dépistage et de prise en charge du diabète chez les enfants atteints de mucoviscidose à Bordeaux
39. 285 Comprehensive management of senso-motor disorders of orality in paediatric CF patients
40. 184 Determinants of nontuberculous mycobacteria eradication in cystic fibrosis
41. 82 Secondary prophylactic antibiotics against Staphylococcus aureus (Sa) during the winter months in children with cystic fibrosis
42. Suivi longitudinal de la mesure d’élasticité hépatique par Fibroscan® chez les enfants atteints de mucoviscidose
43. 435 Fully Automated and Single-Molecule Quantitative in Situ Hybridization for Histopathological Visualization of RNA Biomarkers
44. A compelling argument for routine use of RNAScope in oropharynx SCC HPV testing
45. 144 Comparison of coronary vasoreactivity in end-stage renal disease patients receiving conventional intermittent vs. nocturnal hemodialysis
46. 182 Exhaled breath condensate (EBC) oxidative stress in children with cystic fibrosis
47. Éditorial
48. P058 LUNG MEMBRANE DIFFUSION AND CAPILLARY VOLUME IN CROHN'S DISEASE: A PILOT STUDY
49. Neonatal CF screening (2003–2008) in the Aquitaine region in France: high probability of a second CFTR gene mutation in heterozygotes with subnormal sweat tests
50. 369* Nasal potential difference in hypertrypsinemic children
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.